Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Danaher

A whale with a lot of money to spend has taken a noticeably bearish stance on Danaher. Looking at options history for Danaher (NYSE:DHR) we detected 10 strange trades.

Benzinga

This Is What Whales Are Betting On Danaher

A whale with a lot of money to spend has taken a noticeably bearish stance on Danaher. Looking at options history for Danaher (NYSE:DHR) we detected 10 strange trades.

Benzinga

Star Investor Loeb Increases Equity Exposure

Plenty of other investors believe that the stock market’s rise from June 16 to Aug. 16 is just a bear market rally.

The Street

From analysis to the latest developments in health,
read the most diverse news in one place.

Danaher's Covid Tailwind Is In Question; Why One Analyst Isn't Worried

Danaher crushed second-quarter expectations Thursday, bolstered by strong Covid testing sales. DHR stock surged higher.

Investors Business Daily

How Is The Market Feeling About Danaher?

Danaher's (NYSE:DHR) short percent of float has fallen 7.35% since its last report. The company recently reported that it has 3.99 million shares sold short, which is 0.63% of all regular shares that are available for trading.

Benzinga

Here's How Much $100 Invested In Danaher 20 Years Ago Would Be Worth Today

Danaher (NYSE:DHR) has outperformed the market over the past 20 years by 7.67% on an annualized basis producing an average annual return of 14.78%. Currently, Danaher has a market capitalization of $186.88 billion.

Benzinga

'Skin and bones' dog unrecognisable after being rescued by RSPCA

Lurcher Emily weighed just 10.8kg when she was taken into the RSPCA's Danaher Animal Home's care - but thankfully she was quickly snapped up by a lovely new family

Daily Mirror

Read news from The Economist, FT, and more,
with one subscription

$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today

Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 9.25% on an annualized basis producing an average annual return of 20.62%. Currently, Danaher has a market capitalization of $184.66 billion.

Benzinga

Danaher's Defensive Portfolio Is Ideal Amid Macro Fears: RBC Analyst

Danaher Corporation’s (NYSE: DHR) portfolio, with 75% recurring revenues and more than a 90% mix in life sciences and diagnostics, appears “incrementally more attractive” amid the currently harsh macro environment, according to RBC Capital Markets.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022

Upgrades

Benzinga

Peering Into Danaher's Recent Short Interest

Danaher's (NYSE:DHR) short percent of float has fallen 5.0% since its last report. The company recently reported that it has 4.92 million shares sold short, which is 0.76% of all regular shares that are available for trading.

Benzinga

Here's How Much $100 Invested In Danaher 10 Years Ago Would Be Worth Today

Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 8.15% on an annualized basis producing an average annual return of 19.71%. Currently, Danaher has a market capitalization of $180.36 billion.

Benzinga

Analyst Ratings for Danaher

Danaher (NYSE:DHR) has observed the following analyst ratings within the last quarter:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

This Is What Whales Are Betting On Danaher

A whale with a lot of money to spend has taken a noticeably bearish stance on Danaher. Looking at options history for Danaher (NYSE:DHR) we detected 11 strange trades.

Benzinga

Danaher Clocks Q1 Sales Jump Of 12%, COVID-19-Related Restrictions In China To Impact Q2 Sales

Danaher Corp (NYSE:DHR) logged Q1 FY22 adjusted EPS of $2.76, up 9.5% Y/Y, surpassing the estimate of $2.66. Sales increased 12% to $7.7 billion, with 12% non-GAAP core and 8.0% non-GAAP base business core revenue growth, beating the $7.54 billion estimate. Operating cash flow reached $2 billion. Non-GAAP free cash flow reached…

Benzinga

Danaher: Q1 Earnings Insights

Danaher (NYSE:DHR) reported its Q1 earnings results on Thursday, April 21, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga

Earnings Preview For Danaher

Danaher (NYSE:DHR) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement. Analysts estimate that Danaher will report an earnings per share (EPS) of $2.66.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Here's How Much $1000 Invested In Danaher 15 Years Ago Would Be Worth Today

Danaher (NYSE:DHR) has outperformed the market over the past 15 years by 7.05% on an annualized basis producing an average annual return of 14.59%. Currently, Danaher has a market capitalization of $195.51 billion.

Benzinga

What Are Whales Doing With Danaher

A whale with a lot of money to spend has taken a noticeably bearish stance on Danaher. Looking at options history for Danaher (NYSE:DHR) we detected 12 strange trades.

Investors Business Daily

Danaher Stock Joins Elite Top-Rated List

On Wednesday, Danaher stock got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96.

Benzinga

Here's How Much You Would Have Made Owning Danaher Stock In The Last 15 Years

Danaher (NYSE:DHR) has outperformed the market over the past 15 years by 7.23% on an annualized basis producing an average annual return of 15.22%. Currently, Danaher has a market capitalization of $212.45 billion.

Benzinga

Looking At Danaher's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Danaher (NYSE:DHR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much

Danaher (NYSE:DHR) has outperformed the market over the past 20 years by 7.58% on an annualized basis.

StockNews.com

Thermo Fisher Scientific vs. Danaher: Which Diagnostics & Research Stock is a Better Buy?

Rising demand for advanced diagnostic devices for predicting the early development of diseases and getting accurate results within less time should drive the diagnostics and research industry’s growth. Given the rising investments in the industry, prominent players in this space, Thermo Fisher (TMO) and Danaher (DHR) should benefit. But which…

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.